Treatment: Immunomodulatory Drugs and Rituximab

Hart, Phil A.; Chari, Suresh T.

doi:10.1007/978-3-642-55086-7_23

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These immunomodulatory agents are often used in the treatment of autoimmune hepatitis (AIH). 26 With respect to the biomarkers of AIP, although a cutoff value of serum IgG4 has been determined, 27 we believe that the values for initial diagnosis and prediction of clinical relapse should be differentiated. Although IgG usually normalizes, there are instances where it does not, even in the remission phase [normalization rate (< 135 mg/dL): 52% in the present series].…”

Section: Discussionmentioning

confidence: 99%